Sonoma Pharmaceuticals Future Growth
Future criteria checks 2/6
Sonoma Pharmaceuticals is forecast to grow earnings and revenue by 43.7% and 24.4% per annum respectively while EPS is expected to grow by 58.5% per annum.
Key information
43.7%
Earnings growth rate
58.5%
EPS growth rate
Pharmaceuticals earnings growth | 22.8% |
Revenue growth rate | 24.4% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 25 Mar 2024 |
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2026 | 22 | -1 | N/A | 1 | 1 |
3/31/2025 | 18 | -4 | N/A | -2 | 1 |
3/31/2024 | 15 | -5 | N/A | -4 | 1 |
12/31/2023 | 12 | -5 | -5 | -5 | N/A |
9/30/2023 | 12 | -6 | -4 | -4 | N/A |
6/30/2023 | 13 | -6 | -5 | -5 | N/A |
3/31/2023 | 13 | -5 | -6 | -6 | N/A |
12/31/2022 | 13 | -7 | -5 | -5 | N/A |
9/30/2022 | 13 | -6 | -5 | -5 | N/A |
6/30/2022 | 13 | -5 | -5 | -5 | N/A |
3/31/2022 | 13 | -5 | -4 | -4 | N/A |
12/31/2021 | 12 | -6 | -4 | -4 | N/A |
9/30/2021 | 15 | -5 | -3 | -3 | N/A |
6/30/2021 | 17 | -5 | -2 | -2 | N/A |
3/31/2021 | 19 | -5 | -4 | -3 | N/A |
12/31/2020 | 21 | -3 | -6 | -5 | N/A |
9/30/2020 | 20 | -4 | -7 | -7 | N/A |
6/30/2020 | 19 | -5 | -8 | -8 | N/A |
3/31/2020 | 18 | -4 | -5 | -5 | N/A |
12/31/2019 | 18 | -5 | -4 | -4 | N/A |
9/30/2019 | 19 | -6 | -5 | -5 | N/A |
6/30/2019 | 19 | -8 | -8 | -8 | N/A |
3/31/2019 | 19 | -12 | -12 | -12 | N/A |
12/31/2018 | 18 | -13 | -12 | -12 | N/A |
9/30/2018 | 18 | -14 | -12 | -12 | N/A |
6/30/2018 | 17 | -14 | -11 | -11 | N/A |
3/31/2018 | 17 | -14 | -13 | -12 | N/A |
12/31/2017 | 17 | -12 | -12 | -12 | N/A |
9/30/2017 | 16 | -9 | N/A | -11 | N/A |
6/30/2017 | 14 | -9 | N/A | -10 | N/A |
3/31/2017 | 13 | -9 | N/A | -8 | N/A |
12/31/2016 | 11 | -9 | N/A | -7 | N/A |
9/30/2016 | 10 | -14 | N/A | -8 | N/A |
6/30/2016 | 8 | -16 | N/A | -9 | N/A |
3/31/2016 | 9 | -15 | N/A | -9 | N/A |
12/31/2015 | 11 | -13 | N/A | -10 | N/A |
9/30/2015 | 12 | -14 | N/A | -8 | N/A |
6/30/2015 | 14 | -10 | N/A | -8 | N/A |
3/31/2015 | 14 | -8 | N/A | -7 | N/A |
12/31/2014 | 13 | 1 | N/A | -6 | N/A |
9/30/2014 | 13 | 6 | N/A | -5 | N/A |
6/30/2014 | 14 | 5 | N/A | -5 | N/A |
3/31/2014 | 14 | 4 | N/A | -5 | N/A |
12/31/2013 | 14 | -6 | N/A | -4 | N/A |
9/30/2013 | 14 | -7 | N/A | -5 | N/A |
6/30/2013 | 15 | -8 | N/A | 1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SNOA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: SNOA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: SNOA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: SNOA's revenue (24.4% per year) is forecast to grow faster than the US market (8.2% per year).
High Growth Revenue: SNOA's revenue (24.4% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SNOA's Return on Equity is forecast to be high in 3 years time